Loading the player...
Changing Endpoints in PAH Trials
Share by Email
Send to social websites
Report this video as inappropriate
You can report this video if you think it to be inappropriate, we will review your submission soon. If your reason is not listed here, like copyright infringements, please contact us directly by email.
Select your reason
Violent or Repulsive Content
Hateful or Abusive Content
Harmful Dangerous Acts
Dr. Sean Studer discusses the evolution of clinical trial endpoints in PAH and the impact on current and future treatment
Perspectives on PH: Nick Kim discusses the results of the PATENT 1 trial
Perspectives on PH: Nick Kim discusses the results of the CHEST study
Perspectives on PH: Vallerie McLaughlin discusses the results of the SERAPHIN trial
ATS 2014: The Impact of Macitentan on Functional Class
CHEST 2014: Highlights of AMBITION and COMPASS II
Psychosocial Implications in PAH
Role of Prostacyclins in the Treatment of PAH
Importance of Right Heart Function in PAH
Copyright 2019 by NSCI Group, Inc.
On The Go
About MedEd On The Go